Abbott’s Updated COVID, Flu Test Platform Gets FDA Clearance
Abbott’s ID NOW 2.0 point-of-care diagnostic testing platform received 510K clearance and CLIA waiver from the U.S. FDA.
Read MorePosted by Andy Lundin | Aug 28, 2023 | Covid 19 |
Abbott’s ID NOW 2.0 point-of-care diagnostic testing platform received 510K clearance and CLIA waiver from the U.S. FDA.
Read MorePosted by Chris Wolski | Aug 22, 2023 | Miscellaneous |
In the wake of COVID-19 there is a clear benefit for a collaborative approach between clinical labs and the entire health care enterprise.
Read MorePosted by Andy Lundin | Aug 22, 2023 | Covid 19 |
iHealth Labs, a provider of at-home COVID tests, announced its manufacturing facility for COVID tests manufactured over 70 million test kits.
Read MorePosted by Andy Lundin | Aug 21, 2023 | Covid 19 |
Sensible Diagnostics was selected by the RADx Tech program launched by the NIBIB, which is part of the National Institutes of Health (NIH).
Read MorePosted by Andy Lundin | Aug 16, 2023 | Covid 19, Mass Spectrometry Reagents & Test Kits |
The new COVID detection method employs equipment already being used in hospitals and labs to detect bacterial and fungal infections.
Read More